Kayle Leogrande receives two-year suspension following hearing
Note: The U.S. Anti-Doping Agency issued the following release today regarding U.S. cyclist Kayle Leogrande.
The unanimous decision of a three-person, independent panel of arbitrators from the American Arbitration Association/North American Court of Arbitration for Sport that Leogrande committed an anti-doping rule violation without testing positive or admitting guilt is the first of its kind for an American cycling athlete. USA Cycling will carry out the two-year sanction.
COLORADO SPRINGS, CO - December 1, 2008 - USADA announced today that a three-person, independent panel of arbitrators from the American Arbitration Association (AAA)/North American Court of Arbitration for Sport (CAS) has ruled that Kayle Leogrande of Rancho Cucamunga, CA, an athlete in the sport of cycling, committed an anti-doping rule violation.
The AAA/CAS panel found that Leogrande, 31, used the Prohibited Substance, erythropoietin (EPO), when competing in The Point Premium Root Beer International Cycling Classic, on July 26, 2007. Use of a Prohibited Substance is an anti-doping rule violation under the USADA Protocol and the Union Cycliste Internationale Anti-Doping Rules, both of which adopt the World Anti-Doping Code.
Following a full evidentiary hearing, the unanimous AAA/CAS panel ruled that Leogrande’s “clear and repeated admissions of doping, which in and of themselves may be sufficient to establish an anti-doping rule violation, are corroborated by a significant amount of circumstantial as well as scientific evidence.”
The AAA/CAS panel sanctioned Leogrande for the maximum period of ineligibility of two years commencing on the date of its decision, December 1, 2008, through November 30, 2010. In addition, all competitive results obtained during The Point Premium Root Beer International Cycling Classic and all subsequent results obtained the through the date of this decision, December 1, 2008, shall be disqualified.
"All those who value clean sport should be encouraged by this decision and by those who voluntarily come forward with reliable evidence, placing their trust in USADA, to aggressively pursue those who will cheat their fellow competitors by using prohibited drugs,” said USADA CEO Travis T. Tygart.
NOTE: The AAA/CAS decision is available on the USADA Web site at: http://www.usantidoping.org/files/active/arbitration_rulings/AAA%20Leogrande%20Award%20Signed%20111%20(2).pdf
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited Substance Guide, easy-reference wallet cards, periodic newsletters, and complete athlete toolkits.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
Erin Hannan, Publications & Communications Director
Phone: (719) 785-2009
This Article Published December 1, 2008 For more information contact: